495 related articles for article (PubMed ID: 9587681)
1. Cellular vaccine therapies for cancer.
Mastrangelo MJ; Sato T; Lattime EC; Maguire HC; Berd D
Cancer Treat Res; 1998; 94():35-50. PubMed ID: 9587681
[No Abstract] [Full Text] [Related]
2. Immunotherapy of renal cell carcinoma.
Gouttefangeas C; Stenzl A; Stevanović S; Rammensee HG
Cancer Immunol Immunother; 2007 Jan; 56(1):117-28. PubMed ID: 16676181
[TBL] [Abstract][Full Text] [Related]
3. Vaccination strategies in patients with renal cell carcinoma.
Asemissen AM; Brossart P
Cancer Immunol Immunother; 2009 Jul; 58(7):1169-74. PubMed ID: 19360405
[TBL] [Abstract][Full Text] [Related]
4. Adoptive-cell-transfer therapy for the treatment of patients with cancer.
Dudley ME; Rosenberg SA
Nat Rev Cancer; 2003 Sep; 3(9):666-75. PubMed ID: 12951585
[TBL] [Abstract][Full Text] [Related]
5. Fifth European progress in vaccination against cancer conference, PIVAC 5.
Cavallo F; Baxevanis CN
Cancer Immunol Immunother; 2006 Jul; 55(7):884-90. PubMed ID: 16408212
[No Abstract] [Full Text] [Related]
6. Adjuvant immunotherapy for solid tumors: from promise to clinical application.
Mocellin S; Rossi CR; Lise M; Marincola FM
Cancer Immunol Immunother; 2002 Dec; 51(11-12):583-95. PubMed ID: 12439603
[TBL] [Abstract][Full Text] [Related]
7. Recent Findings on Therapeutic Cancer Vaccines: An Updated Review.
Sheikhlary S; Lopez DH; Moghimi S; Sun B
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672519
[TBL] [Abstract][Full Text] [Related]
8. Cancer testis antigens and melanoma stem cells: new promises for therapeutic intervention.
Sigalotti L; Covre A; Nicolay HJ; Coral S; Maio M
Cancer Immunol Immunother; 2010 Mar; 59(3):487-8. PubMed ID: 19862522
[No Abstract] [Full Text] [Related]
9. International conference: progress in vaccination against cancer-2006 (PIVAC 6), Granada, Spain.
Aptsiauri N; Cabrera T; Pawelec G; Gouttefangeas C; Derhovanessian E; Garrido F; Garcia-Lora A
Cancer Immunol Immunother; 2007 Aug; 56(8):1311-22. PubMed ID: 17375297
[No Abstract] [Full Text] [Related]
10. Report on the sixth annual meeting of the Association for Immunotherapy of Cancer (CIMT), May 15 and 16, 2008 in Mainz, Germany.
Welters MJ; van Montfoort N; Khan S; Meyer RG; Britten CM
Cancer Immunol Immunother; 2009 May; 58(5):777-87. PubMed ID: 18982325
[No Abstract] [Full Text] [Related]
11. Tumor initiation in human malignant melanoma and potential cancer therapies.
Ma J; Frank MH
Anticancer Agents Med Chem; 2010 Feb; 10(2):131-6. PubMed ID: 20184545
[TBL] [Abstract][Full Text] [Related]
12. Sixth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, 16-18 October 2008.
Maio M; Nicolay HJ; Ascierto PA; Belardelli F; Camerini R; Colombo MP; Queirolo P; Ridolfi R; Russo V; Fonsatti E; Parmiani G;
Cancer Immunol Immunother; 2010 Jun; 59(6):963-9. PubMed ID: 19330329
[No Abstract] [Full Text] [Related]
13. "Tumor immunology meets oncology IV", 23rd and 24th May 2008 Martin Luther University Halle-Wittenberg, Halle, Germany.
Bukur J; Loeffler D; Massa C; Mueller L; Riemann D; Schmoll HJ; Seliger B
Cancer Immunol Immunother; 2010 Jun; 59(6):955-62. PubMed ID: 18751976
[No Abstract] [Full Text] [Related]
14. Tumor cells engineered to produce cytokines or cofactors as cellular vaccines: do animal studies really support clinical trials?
Colombo MP; Rodolfo M
Cancer Immunol Immunother; 1995 Nov; 41(5):265-70. PubMed ID: 8536271
[No Abstract] [Full Text] [Related]
15. Effects of melatonin, its precursors and derivatives on the growth of cultured human uveal melanoma cells.
Hu DN; McCormick SA; Roberts JE
Melanoma Res; 1998 Jun; 8(3):205-10. PubMed ID: 9664141
[TBL] [Abstract][Full Text] [Related]
16. Ex-vivo gene therapy using cytokine-transduced tumor vaccines: molecular and clinical pharmacology.
Simons JW; Mikhak B
Semin Oncol; 1998 Dec; 25(6):661-76. PubMed ID: 9865681
[TBL] [Abstract][Full Text] [Related]
17. Melanoma-specific cytotoxicity induced by a tyrosinase promoter-enhancer/herpes simplex virus thymidine kinase adenovirus.
Siders WM; Halloran PJ; Fenton RG
Cancer Gene Ther; 1998; 5(5):281-91. PubMed ID: 9824047
[TBL] [Abstract][Full Text] [Related]
18. New aspects of immunotherapy of leptomeningeal metastasis.
Herrlinger U; Weller M; Schabet M
J Neurooncol; 1998; 38(2-3):233-9. PubMed ID: 9696377
[TBL] [Abstract][Full Text] [Related]
19. Extension of useful reagent shelf life beyond manufacturers' recommendations. Cell Markers Committee of the College of American Pathologists.
Tubbs RR; Nagle R; Leslie K; Pettigrew NM; Said JW; Corwin DJ; Rickert RR; Roche PC
Arch Pathol Lab Med; 1998 Dec; 122(12):1051-2. PubMed ID: 9870851
[TBL] [Abstract][Full Text] [Related]
20. Expression of the insulin-like growth factor-1 receptor and its anti-apoptotic effect in malignant melanoma: a potential therapeutic target.
Kanter-Lewensohn L; Dricu A; Wang M; Wejde J; Kiessling R; Larsson O
Melanoma Res; 1998 Oct; 8(5):389-97. PubMed ID: 9835451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
